Landmark Clinical Trial Results in First FDA-Approved Treatment for Rare Form of Obesity Caused by Brain Injury
Children and adults living with a rare condition that causes rapid, uncontrollable weight gain now have a new treatment option following the U.S. Food and Drug Administration's approval of setmelanotide.
